Vascular endothelial growth factor mRNA levels quantified by reverse transcription-polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components

Pathology International

Volumn 55, Issue 5, 2005, Pages 255-263

  Yamasaki, Tamio ^a   Tsuda, Hitoshi ^a   Imazeki, Nobuo ^a   Matsubara, Osamu ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Breast cancer; Immunochemistry; Microdissection; Quantitative RT PCR; VEGF

Indexed keywords

HORMONE RECEPTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST INVASIVE DUCTAL CARCINOMA; CANCER CELL; CANCER GRADING; CLINICAL ARTICLE; COMEDO; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TISSUE TYPES; TUMOR GROWTH; TUMOR VOLUME; VEGF GENE;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICRODISSECTION; MIDDLE AGED; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 20444439540     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2005.01822.x     Document Type: Article

References (37)

1. Salven P, Lymboussaki A, Heikkila P et al. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 1998; 153:103-8.
2. Fine BA, Valente PT, Feinstein GI, Dey T. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma. Gynecol Oncol 2000; 76: 33-9.
3. Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439-42.
4. Carmeliet P, Ferreira V, Breier G et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-9.
5. Tischer E, Mitchell R, Hartman T et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 11 947-54.
6. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5: 1806-14.
7. Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer 1997; 79: 206-13.
8. Relf M, LeJeune S, Scott PA et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997; 57: 963-9.
9. Engels K, Fox SB, Harris AL. Angiogenesis as a biologic and prognostic indicator in human breast carcinoma. EXS 1997; 79: 113-56.
10. Eppenberger U, Kueng W, Schlaeppi JM et al. Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J Clin Oncol 1998; 16: 3129-36.
11. Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 2000; 5: 37-44.
12. Linderholm B, Lindh B, Tavelin B, Grankvist K, Henriksson R. p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int J Cancer 2000; 89: 51-62.
13. Emmert-Buck MR, Bonner RF, Smith PD et al. Laser capture microdissection. Science 1996; 274: 998-1001.
14. Bonner RF, Emmert-Buck M, Cole K et al. Laser capture microdissection: molecular analysis of tissue. Science 1997; 278: 1483.
15. Goldsworthy SM, Stockton PS, Trempus CS, Foley JF, Maronpot RR. Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue. Mol Carcinog 1999; 25: 86-91.
16. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res 1996; 6: 995-1001.
17. Fink L, Seeger W, Ermert L et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 1998; 4: 1329-33.
18. Japanese Breast Cancer Society. General Rules for Clinical and Pathological Recording of Breast Cancer, 15th edn. Tokyo: Kanehara Shuppan, 2004 (in Japanese).
19. Rosen PP, Oberman HA. Intraductal carcinoma. In: Rosen PP, Oberman HA, eds. Tumors of the Mammary Gland. Atlas of Tumor Pathology, 3rd Series, Fascicle 7. Washington DC: Armed Forces Institute of Pathology, 1993; 143-53.
20. Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 1992; 20: 479-89.
21. Shimizu H, Schnurr DP, Burns JC. Comparison of methods to detect enteroviral genome in frozen and fixed myocardium by polymerase chain reaction. Lab Invest 1994; 71: 612-16.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
23. Schlaeppi JM, Eppenberger U, Martiny-Baron G, Kung W. Chemiluminescence immunoassay for vascular endothelial growth factor (vascular permeability factor) in tumor-tissue homogenates. Clin Chem 1996; 42: 1777-84.
24. Greb RR, Maier l, Wallwiener D, Kiesel L. Vascular endothelial growth factor A (VEGF-A) mRNA expression levels decrease after menopause in normal breast tissue but not in breast cancer lesions. Br J Cancer 1999; 81: 225-31.
25. Sakamoto G. Infiltrating carcinoma: major histological types. In: Page DL, Anderson TJ, eds. Diagnostic Histopathology of the Breast. Edinburgh: Churchill Livingstone, 1987; 193-235.
26. Silverstein MJ, Lagios MD, Craig PH et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996; 77: 2267-74.
27. Petit AM, Rak J, Hung MC et al. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol 1997; 151: 1523-30.
28. Locopo N, Fanelli M, Gasparini G. Clinical significance of angiogenic factors in breast cancer. Breast Cancer Res Treat 1998; 52: 159-73.
29. Holash J, Maisonpierre PC, Compton D et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284: 1994-8.
30. Hajitou A. Deroanne C, Noel A et al. Progression in MCF-7 breast cancer cell tumorigenicity: compared effect of FGF-3 and FGF-4. Breast Cancer Res Treat 2000; 60: 15-28.
31. Brown LF, Berse B, Jackman RW et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995; 26: 86-91.
32. Scott PA, Smith K, Poulsom R, De Benedetti A, Bicknell R, Harris AL. Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to elF-4E. Br J Cancer 1998; 77: 2120-28.
33. Wiborg O, Pedersen MS, Wind A, Berglund LE, Marcker KA, Vuust J. The human ubiquitin multigene family: some genes contain multiple directly repeated ubiquitin coding sequences. EMBO J 1985; 4: 755-9.
34. Wright PS, Loudy DE, Cross-Doersen DE et al. Quantitation of vascular endothelial growth factor mRNA levels in human breast tumors and metastatic lymph nodes. Exp Mol Pathol 1997; 64: 41-51.
35. Lewis CE, Leek R, Harris A, McGee JO. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol 1995; 57: 747-51.
36. Shoji M, Hancock WW, Abe K et al. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol 1998; 152: 399-411.
37. Ueno T, Toi M, Saji H et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 2000; 6: 3282-9.